{"id":2478,"date":"2020-06-11T13:26:45","date_gmt":"2020-06-11T17:26:45","guid":{"rendered":"https:\/\/www.med.unc.edu\/medicine\/uncaap\/?page_id=2478"},"modified":"2020-08-13T16:35:01","modified_gmt":"2020-08-13T20:35:01","slug":"ponente","status":"publish","type":"page","link":"https:\/\/www.med.unc.edu\/medicine\/uncaap\/ponente\/","title":{"rendered":"PONENTE study"},"content":{"rendered":"<p>The UNC AAP is participating in PONENTE, a multi-center study designed to evaluate the efficacy and safety of reducing daily oral corticosteroids after initiation of benralizumab (Fasenra) administered subcutaneously in patients with severe eosinophilic asthma.<\/p>\n<p class=\"xmsonormal\"><span style=\"font-size: 11.0pt\">\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The UNC AAP is participating in PONENTE, a multi-center study designed to evaluate the efficacy and safety of reducing daily oral corticosteroids after initiation of benralizumab (Fasenra) administered subcutaneously in patients with severe eosinophilic asthma. \u00a0<\/p>\n","protected":false},"author":25536,"featured_media":0,"parent":0,"menu_order":2,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-2478","page","type-page","status-publish","hentry","odd"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PONENTE study - UNC Adult Asthma Program<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.med.unc.edu\/medicine\/uncaap\/ponente\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PONENTE study - UNC Adult Asthma Program\" \/>\n<meta property=\"og:description\" content=\"The UNC AAP is participating in PONENTE, a multi-center study designed to evaluate the efficacy and safety of reducing daily oral corticosteroids after initiation of benralizumab (Fasenra) administered subcutaneously in patients with severe eosinophilic asthma. \u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.med.unc.edu\/medicine\/uncaap\/ponente\/\" \/>\n<meta property=\"og:site_name\" content=\"UNC Adult Asthma Program\" \/>\n<meta property=\"article:modified_time\" content=\"2020-08-13T20:35:01+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/uncaap\/ponente\/\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/uncaap\/ponente\/\",\"name\":\"PONENTE study - UNC Adult Asthma Program\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/uncaap\/#website\"},\"datePublished\":\"2020-06-11T17:26:45+00:00\",\"dateModified\":\"2020-08-13T20:35:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/uncaap\/ponente\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.med.unc.edu\/medicine\/uncaap\/ponente\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/uncaap\/ponente\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.med.unc.edu\/medicine\/uncaap\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PONENTE study\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/uncaap\/#website\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/uncaap\/\",\"name\":\"UNC Adult Asthma Program\",\"description\":\"Department of Medicine\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.med.unc.edu\/medicine\/uncaap\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PONENTE study - UNC Adult Asthma Program","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.med.unc.edu\/medicine\/uncaap\/ponente\/","og_locale":"en_US","og_type":"article","og_title":"PONENTE study - UNC Adult Asthma Program","og_description":"The UNC AAP is participating in PONENTE, a multi-center study designed to evaluate the efficacy and safety of reducing daily oral corticosteroids after initiation of benralizumab (Fasenra) administered subcutaneously in patients with severe eosinophilic asthma. \u00a0","og_url":"https:\/\/www.med.unc.edu\/medicine\/uncaap\/ponente\/","og_site_name":"UNC Adult Asthma Program","article_modified_time":"2020-08-13T20:35:01+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.med.unc.edu\/medicine\/uncaap\/ponente\/","url":"https:\/\/www.med.unc.edu\/medicine\/uncaap\/ponente\/","name":"PONENTE study - UNC Adult Asthma Program","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/medicine\/uncaap\/#website"},"datePublished":"2020-06-11T17:26:45+00:00","dateModified":"2020-08-13T20:35:01+00:00","breadcrumb":{"@id":"https:\/\/www.med.unc.edu\/medicine\/uncaap\/ponente\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.med.unc.edu\/medicine\/uncaap\/ponente\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.med.unc.edu\/medicine\/uncaap\/ponente\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.med.unc.edu\/medicine\/uncaap\/"},{"@type":"ListItem","position":2,"name":"PONENTE study"}]},{"@type":"WebSite","@id":"https:\/\/www.med.unc.edu\/medicine\/uncaap\/#website","url":"https:\/\/www.med.unc.edu\/medicine\/uncaap\/","name":"UNC Adult Asthma Program","description":"Department of Medicine","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.med.unc.edu\/medicine\/uncaap\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links_to":[],"_links_to_target":[],"_links":{"self":[{"href":"https:\/\/www.med.unc.edu\/medicine\/uncaap\/wp-json\/wp\/v2\/pages\/2478","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.unc.edu\/medicine\/uncaap\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.med.unc.edu\/medicine\/uncaap\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/uncaap\/wp-json\/wp\/v2\/users\/25536"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/uncaap\/wp-json\/wp\/v2\/comments?post=2478"}],"version-history":[{"count":0,"href":"https:\/\/www.med.unc.edu\/medicine\/uncaap\/wp-json\/wp\/v2\/pages\/2478\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.med.unc.edu\/medicine\/uncaap\/wp-json\/wp\/v2\/media?parent=2478"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}